BeOne Medicines AG
6160.HK News Today: Stay Updated with the Latest BeOne Medicines AG News in Real Time
Find 6160.HK news now at Meyka AI. Stay informed with the latest BeOne Medicines AG stocks updates, including price news, market analysis, and expert insights.
UK Seizes 12,000 Illegal Weight Loss Doses in Record Raid, May 31
UK authorities seize record 12,000 unlicensed weight loss drug doses in Northamptonshire. Two men arrested under Human Medicines Regulations 2012.
Switzerland Tightens Border Controls and Asylum Security in June 2026
Switzerland enforces asylum center security rules June 1 and upgrades medicine monitoring June 15. Germany maintains border controls.
Zelira Therapeutics Limited (ZLD.AX) Holds A$0.50 as Biotech Sector Stabilizes
ZLD.AX stock trades at A$0.50 on ASX. Zelira Therapeutics holds steady as cannabinoid biotech faces structural headwinds.
Adcock Ingram Holdings Limited (AIHLF) Bounces Back: Stock Up 42.9% Over Six Months
AIHLF stock surges 42.9% in six months as South African pharma giant trades at $3.50 with strong dividend yield of 4.5%.
Pharmadrug Inc. Stock Plummets 33% as Losses Deepen
PHRX.CN stock crashes 33% on May 21 as specialty pharma company faces mounting losses and weak fundamentals in healthcare sector.
Curatis Holding AG Surges 8.5% as Rare Disease Portfolio Gains Traction
CURN.SW stock jumps 8.5% to CHF22.9 on SIX. Specialty pharma company advances rare disease pipeline with multiple clinical trials underway.
RLAY: Raymond James Maintains Strong Buy, Raises Price Target to $26
Raymond James maintains Strong Buy rating on RLAY, raises price target to $26 from $23 on May 19, 2026.
600 Drugs Added to TrumpRx With Mark Cuban and Amazon Collaboration
The healthcare industry in the United States is seeing a major shift after TrumpRx announced the addition of 600 new prescription drugs to its growing platform. The expansion is gaining national attention because of its reported collaboration efforts involving Mark Cuban, Amazon’s pharmacy network, and several healthcare technology partners. The move is expected to improve…
Pharmadrug Inc. (PHRX.CN) Surges 50% on Psychedelic Research Momentum
PHRX.CN stock jumps 50% to C$0.015 on specialty pharma research progress. Track Pharmadrug Inc. gains today.